查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1475824

生命科学领域全球製造执行系统市场规模研究与预测，依解决方案类型、部署、最终用户（製药和生物技术公司、医疗器材公司等）和区域分析，2023-2030 年

Global Manufacturing Execution System in Life Sciences Market Size Study & Forecast, By Solution Type By Deployment, By End-user (Pharmaceutical and Biotechnology Companies, Medical Device Companies, Others ) and Regional Analysis, 2023-2030
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 200 Pages | 商品交期: 2-3个工作天内

价格

2022年，全球生命科学製造执行系统市场价值约为24.7亿美元，预计在2023-2030年预测期内将以超过12.20%的健康成长率成长。生命科学领域的製造执行系统 (MES) 是指基于软体的解决方案，旨在管理和控制製药、生物技术和医疗器材产业的製造流程。 MES 有助于即时监控、追踪和执行製造操作，从原材料准备到成品包装。生物製药行业的日益突出、技术进步的不断进步以及製药 4.0 的采用率上升，成为推动生命科学行业对製造执行系统 (MES) 需求的关键驱动因素。製药业拥抱数位转型、推动製药 4.0 以及生命科学市场中 MES 的采用正在兴起。製药 4.0 计画旨在增强连接性、生产力、合规性和资讯管理，从而为产业挑战提供更有效的解决方案。

製药业日益数位化正在推动对 Pharma 4.0 的需求，这是生命科学领域製造执行系统市场扩张的重要因素。 Pharma 4.0 有助于提高连接性和生产力，同时简化合规工作，并透过增强的生产资讯管理来快速回应新出现的问题。该模型透过培育更加以人为本的工作流程并更有效地连接工人，彻底改变了製造流程。国际製药工程学会 (ISPE) 及其成员正在积极制定引入 Pharma 4.0 的路线图，旨在帮助组织充分利用数位化的潜力，实现更快的治疗创新和改进的生产流程，最终造福患者。 Pharma 4.0 生态系统内的主要利害关係人正在合作加速其采用。例如，2021 年 3 月，Lonza 和 NNIT 宣布建立策略合作伙伴关係，旨在加速 MES 专案。此次合作将 Lonza 的 MODA 平台与 NNIT 的加速实施方法相集成，为组织提供全面的 Pharma 4.0 解决方案，并促进其加速数位化目标。因此，製药 4.0 的日益普及推动了生命科学产业製造执行系统市场的成长。此外，生命科学产业的全球化和生物开发的严格监管要求正在为市场成长创造新的机会。然而，高昂的实施成本以及资料安全和隐私问题抑制了 2023-2030 年预测期内的市场成长。

生命科学市场全球製造执行系统研究考虑的关键区域包括亚太地区、北美、欧洲、拉丁美洲以及中东和非洲。由于技术进步和製药行业製造流程的日益数位化是推动北美市场成长的关键因素，北美将在 2022 年占据主导地位。此外，市场受益于艾默生电气公司和罗克韦尔自动化等有影响力的行业参与者的存在，它们为简化医疗保健製造流程做出了重大贡献。此外，整合实验室自动化解决方案的采用为 MES 供应商提供了充满希望的成长途径。例如，Automata 计划于 2023 年 2 月在美国扩展其服务，这就是市场不断扩大的机会的例证。由于生物技术产业的崛起、临床试验数量的增加以及政府对该地区生命科学产业的支持力度加大等因素，预计亚太地区在预测期内将出现显着增长。

研究的目的是确定近年来不同细分市场和国家的市场规模，并预测未来几年的价值。该报告旨在纳入参与研究的国家内该行业的定性和定量方面。

该报告还提供了有关关键方面的详细信息，例如将决定市场未来成长的驱动因素和挑战。此外，它还纳入了利害关係人投资的微观市场的潜在机会，以及对主要参与者的竞争格局和产品供应的详细分析。

目录

第 1 章：执行摘要

  • 市场概况
  • 2020-2030 年全球与细分市场估计与预测
    • 2020-2030 年生命科学市场製造执行系统（按地区）
    • 2020-2030 年生命科学市场製造执行系统（依解决方案类型）
    • 生命科学市场的製造执行系统，依部署划分，2020-2030 年
    • 生命科学市场製造执行系统，按最终用户划分，2020-2030 年
  • 主要趋势
  • 估算方法
  • 研究假设

第 2 章：生命科学市场定义与范围的全球製造执行系统

  • 研究目的
  • 市场定义和范围
    • 产业演变
    • 研究范围
  • 研究考虑的年份
  • 货币兑换率

第 3 章：生命科学市场动态中的全球製造执行系统

  • 生命科学市场影响分析中的製造执行系统（2020-2030）
    • 市场驱动因素
      • 生物製药产业的地位日益凸显
      • 不断进步的技术
      • 製药 4.0 的采用率上升
    • 市场挑战
      • 实施成本高
      • 资料安全和隐私问题
    • 市场机会
      • 生命科学产业全球化
      • 生物製品开发的严格监管要求

第 4 章：生命科学市场中的全球製造执行系统产业分析

  • 波特的五力模型
    • 供应商的议价能力
    • 买家的议价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争竞争
  • 波特的 5 力影响分析
  • PEST分析
    • 政治的
    • 经济
    • 社会的
    • 技术性
    • 环境的
    • 合法的
  • 顶级投资机会
  • 最佳制胜策略
  • COVID-19 影响分析
  • 颠覆性趋势
  • 产业专家视角
  • 分析师推荐与结论

第 5 章：生命科学市场的全球製造执行系统（依解决方案类型）

  • 市场概况
  • 生命科学市场中的全球製造执行系统（按解决方案类型、性能 - 潜力分析）
  • 2020-2030 年按解决方案类型分類的全球生命科学製造执行系统市场估计与预测
  • 生命科学市场的製造执行系统，細項分析
    • 软体
    • 服务

第 6 章：生命科学市场中的全球製造执行系统（按部署）

  • 市场概况
  • 生命科学市场中的全球製造执行系统（按部署、性能 - 潜力分析）
  • 2020-2030 年生命科学领域全球製造执行系统市场估计与部署预测
  • 生命科学市场的製造执行系统，細項分析
    • 本地部署
    • 基于云端/网路
    • 杂交种

第 7 章：生命科学市场中的全球製造执行系统（按最终用户）

  • 市场概况
  • 生命科学市场中的全球製造执行系统（按最终用户）、性能-潜力分析
  • 2020-2030 年最终用户全球生命科学製造执行系统市场估计与预测
  • 生命科学市场的製造执行系统，細項分析
    • 製药和生物技术公司
    • 医疗器材公司
    • 其他（CDMO、CRO 等）

第 8 章：生命科学市场的全球製造执行系统，区域分析

  • 领先国家
  • 顶尖新兴国家
  • 生命科学市场的製造执行系统，区域市场简介
  • 北美洲
    • 我们
      • 2020-2030 年解决方案类型细分估计与预测
      • 2020-2030 年部署细分估计与预测
      • 2020-2030 年最终用户细分估计与预测
    • 加拿大
  • 欧洲生命科学製造执行系统市场概况
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 亚太生命科学製造执行系统市场概况
    • 中国
    • 印度
    • 日本
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 拉丁美洲生命科学製造执行系统市场概况
    • 巴西
    • 墨西哥
  • 中东和非洲
    • 沙乌地阿拉伯
    • 南非
    • 中东和非洲其他地区

第 9 章：竞争情报

  • 重点企业SWOT分析
  • 顶级市场策略
  • 公司简介
    • Korber AG
      • 关键讯息
      • 概述
      • 财务（视数据可用性而定）
      • 产品概要
      • 最近的发展
    • ABB Laboratories
    • MasterControl Solutions, Inc.
    • AVEVA Group Limited
    • Cognizant Technology Solutions Corporation
    • Rockwell Automation
    • Nagarro, Inc
    • Siemens AG
    • Emerson Electric Co.
    • iBase-t, Inc.

第 10 章：研究过程

  • 研究过程
    • 资料探勘
    • 分析
    • 市场预测
    • 验证
    • 出版
  • 研究属性
  • 研究假设

Global Manufacturing Execution System in Life Sciences Market is valued at approximately USD 2.47 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 12.20% over the forecast period 2023-2030. A Manufacturing Execution System (MES) in life sciences refers to a software-based solution designed to manage and control the manufacturing processes within the pharmaceutical, biotechnology, and medical device industries. MES facilitates the real-time monitoring, tracking, and execution of manufacturing operations, from raw material preparation to finished product packaging. The increasing prominence of the biopharmaceutical sector, rising technological advancements, and the rise in adoption of Pharma 4.0 stand out as key drivers fueling the demand for Manufacturing Execution Systems (MES) within the life sciences sector. The pharmaceutical industry embracing digital transformation, the push for Pharma 4.0, and the adoption of MES in the life sciences market are on the rise. Pharma 4.0 initiatives aim to bolster connectivity, productivity, compliance, and information management, enabling more effective solutions to industry challenges.

The increasing digitization within the pharmaceutical industry is driving the demand for Pharma 4.0, a significant factor contributing to the expansion of the manufacturing execution system market in the life sciences sector. Pharma 4.0 facilitates heightened connectivity and productivity while streamlining compliance efforts and enabling swift response to emerging issues through enhanced production information management. This model revolutionizes manufacturing processes by fostering more human-centric workflows and connecting workers more effectively. The International Society for Pharmaceutical Engineering (ISPE) and its members are actively developing a roadmap to introduce Pharma 4.0, aiming to empower organizations to harness the full potential of digitalization for faster therapeutic innovations and improved production processes, ultimately benefiting patients. Key stakeholders within the Pharma 4.0 ecosystem are collaborating to accelerate its adoption. For example, in March 2021, Lonza and NNIT announced a strategic partnership aimed at expediting MES projects. This collaboration integrates Lonza's MODA Platform with NNIT's Accelerated Implementation Methodology, providing organizations with a comprehensive Pharma 4.0 solution and facilitating the realization of their digitalization goals at an accelerated pace. Consequently, the increasing adoption of Pharma 4.0 drives the growth of the Manufacturing Execution System Market in The Life Sciences Industry. In addition, the globalization of the life sciences industry and stringent regulatory requirements for biological development are creating new opportunities for market growth. However, the high implementation cost and data security and privacy concerns stifle market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Manufacturing Execution System in Life Sciences Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to technological advancements and the increasing digitization of manufacturing processes within the pharmaceutical industry are key factors propelling market growth in North America. Furthermore, the market benefits from the presence of influential industry players like Emerson Electric Co. and Rockwell Automation, which contribute significantly to streamlining healthcare manufacturing processes. Additionally, the adoption of integrated laboratory automation solutions presents promising growth avenues for MES providers. For instance, Automata's plans to expand its services in the U.S. in February 2023 exemplify the market's expanding opportunities. Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as the rising biotechnology industry, rising number of clinical trials, and rising government support for the life science industry in the region.

Major market players included in this report are:

  • Korber AG
  • ABB Laboratories
  • MasterControl Solutions, Inc.
  • AVEVA Group Limited
  • Cognizant Technology Solutions Corporation
  • Rockwell Automation
  • Nagarro, Inc.
  • Siemens AG
  • Emerson Electric Co.
  • iBase-t, Inc.

Recent Developments in the Market:

  • In January 2024, CGI Inc. and Korber AG joined hands to provide an integrated solution tailored to optimize production processes for pharmaceutical and life sciences firms. By merging CGI's end-to-end Solution Types with Korber's Werum PAS-X MES Suite, the partnership endeavours to enhance accuracy, efficiency, and safety throughout the pharmaceutical product development cycle. Additionally, clients gain access to real-time data, empowering them to make informed decisions and elevate overall operational performance.
  • In February 2023, AVEVA Group Limited, a leading industrial software provider, unveiled its latest offering: the AVEVA Manufacturing Execution System. This updated release is designed to streamline the deployment of multi-site MES solutions while mitigating associated costs and complexities. With its enhanced version, AVEVA MES facilitates quicker and more efficient adoption of industry best practices, ultimately driving operational efficiency and sustainability improvements.

Global Manufacturing Execution System in Life Sciences Market Report Scope:

  • Historical Data - 2020 - 2021
  • Base Year for Estimation - 2022
  • Forecast period - 2023-2030
  • Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered - Solution Type, Deployment, End-user, Region
  • Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope - Free report customization (equivalent to up to 8 analysts' working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define the market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters to detailed information about the crucial aspects such as driving factors & challenges that will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Solution Type:

  • Software
  • Services

By Deployment:

  • On-Premise
  • Cloud/Web-Based
  • Hybrid

By End-user:

  • Pharmaceutical and Biotechnology Companies
  • Medical Device Companies
  • Others (CDMOs, CROs, etc.)

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1.Executive Summary

  • 1.1.Market Snapshot
  • 1.2.Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1.Manufacturing Execution System in Life Sciences Market, by Region, 2020-2030 (USD Billion)
    • 1.2.2.Manufacturing Execution System in Life Sciences Market, by Solution Type, 2020-2030 (USD Billion)
    • 1.2.3.Manufacturing Execution System in Life Sciences Market, by Deployment, 2020-2030 (USD Billion)
    • 1.2.4.Manufacturing Execution System in Life Sciences Market, by End-user, 2020-2030 (USD Billion)
  • 1.3.Key Trends
  • 1.4.Estimation Methodology
  • 1.5.Research Assumption

Chapter 2.Global Manufacturing Execution System in Life Sciences Market Definition and Scope

  • 2.1.Objective of the Study
  • 2.2.Market Definition & Scope
    • 2.2.1.Industry Evolution
    • 2.2.2.Scope of the Study
  • 2.3.Years Considered for the Study
  • 2.4.Currency Conversion Rates

Chapter 3.Global Manufacturing Execution System in Life Sciences Market Dynamics

  • 3.1.Manufacturing Execution System in Life Sciences Market Impact Analysis (2020-2030)
    • 3.1.1.Market Drivers
      • 3.1.1.1.Increasing Prominence of Biopharmaceutical Sector
      • 3.1.1.2.Rising Technological Advancements
      • 3.1.1.3.Rise in Adoption of Pharma 4.0
    • 3.1.2.Market Challenges
      • 3.1.2.1.High Implementation Cost
      • 3.1.2.2.Data Security and Privacy Concerns
    • 3.1.3.Market Opportunities
      • 3.1.3.1.Globalization of Life Sciences Industry
      • 3.1.3.2.Stringent Regulatory Requirements for Biologicals Development

Chapter 4.Global Manufacturing Execution System in Life Sciences Market Industry Analysis

  • 4.1.Porter's 5 Force Model
    • 4.1.1.Bargaining Power of Suppliers
    • 4.1.2.Bargaining Power of Buyers
    • 4.1.3.Threat of New Entrants
    • 4.1.4.Threat of Substitutes
    • 4.1.5.Competitive Rivalry
  • 4.2.Porter's 5 Force Impact Analysis
  • 4.3.PEST Analysis
    • 4.3.1.Political
    • 4.3.2.Economical
    • 4.3.3.Social
    • 4.3.4.Technological
    • 4.3.5.Environmental
    • 4.3.6.Legal
  • 4.4.Top investment opportunity
  • 4.5.Top winning strategies
  • 4.6.COVID-19 Impact Analysis
  • 4.7.Disruptive Trends
  • 4.8.Industry Expert Perspective
  • 4.9.Analyst Recommendation & Conclusion

Chapter 5.Global Manufacturing Execution System in Life Sciences Market, by Solution Type

  • 5.1.Market Snapshot
  • 5.2.Global Manufacturing Execution System in Life Sciences Market by Solution Type, Performance - Potential Analysis
  • 5.3.Global Manufacturing Execution System in Life Sciences Market Estimates & Forecasts by Solution Type 2020-2030 (USD Billion)
  • 5.4.Manufacturing Execution System in Life Sciences Market, Sub Segment Analysis
    • 5.4.1. Software
    • 5.4.2.Services

Chapter 6.Global Manufacturing Execution System in Life Sciences Market, by Deployment

  • 6.1.Market Snapshot
  • 6.2.Global Manufacturing Execution System in Life Sciences Market by Deployment, Performance - Potential Analysis
  • 6.3.Global Manufacturing Execution System in Life Sciences Market Estimates & Forecasts by Deployment 2020-2030 (USD Billion)
  • 6.4.Manufacturing Execution System in Life Sciences Market, Sub Segment Analysis
    • 6.4.1. On-Premise
    • 6.4.2.Cloud/Web-Based
    • 6.4.3.Hybrid

Chapter 7.Global Manufacturing Execution System in Life Sciences Market, by End-user

  • 7.1.Market Snapshot
  • 7.2.Global Manufacturing Execution System in Life Sciences Market by End-user, Performance - Potential Analysis
  • 7.3.Global Manufacturing Execution System in Life Sciences Market Estimates & Forecasts by End-user 2020-2030 (USD Billion)
  • 7.4.Manufacturing Execution System in Life Sciences Market, Sub Segment Analysis
    • 7.4.1. Pharmaceutical and Biotechnology Companies
    • 7.4.2.Medical Device Companies
    • 7.4.3.Others (CDMOs, CROs, etc.)

Chapter 8.Global Manufacturing Execution System in Life Sciences Market, Regional Analysis

  • 8.1.Top Leading Countries
  • 8.2.Top Emerging Countries
  • 8.3.Manufacturing Execution System in Life Sciences Market, Regional Market Snapshot
  • 8.4.North America Manufacturing Execution System in Life Sciences Market
    • 8.4.1.U.S. Manufacturing Execution System in Life Sciences Market
      • 8.4.1.1.Solution Type breakdown estimates & forecasts, 2020-2030
      • 8.4.1.2.Deployment breakdown estimates & forecasts, 2020-2030
      • 8.4.1.3.End-user breakdown estimates & forecasts, 2020-2030
    • 8.4.2.Canada Manufacturing Execution System in Life Sciences Market
  • 8.5.Europe Manufacturing Execution System in Life Sciences Market Snapshot
    • 8.5.1.U.K. Manufacturing Execution System in Life Sciences Market
    • 8.5.2.Germany Manufacturing Execution System in Life Sciences Market
    • 8.5.3.France Manufacturing Execution System in Life Sciences Market
    • 8.5.4.Spain Manufacturing Execution System in Life Sciences Market
    • 8.5.5.Italy Manufacturing Execution System in Life Sciences Market
    • 8.5.6.Rest of Europe Manufacturing Execution System in Life Sciences Market
  • 8.6.Asia-Pacific Manufacturing Execution System in Life Sciences Market Snapshot
    • 8.6.1.China Manufacturing Execution System in Life Sciences Market
    • 8.6.2.India Manufacturing Execution System in Life Sciences Market
    • 8.6.3.Japan Manufacturing Execution System in Life Sciences Market
    • 8.6.4.Australia Manufacturing Execution System in Life Sciences Market
    • 8.6.5.South Korea Manufacturing Execution System in Life Sciences Market
    • 8.6.6.Rest of Asia Pacific Manufacturing Execution System in Life Sciences Market
  • 8.7.Latin America Manufacturing Execution System in Life Sciences Market Snapshot
    • 8.7.1.Brazil Manufacturing Execution System in Life Sciences Market
    • 8.7.2.Mexico Manufacturing Execution System in Life Sciences Market
  • 8.8.Middle East & Africa Manufacturing Execution System in Life Sciences Market
    • 8.8.1.Saudi Arabia Manufacturing Execution System in Life Sciences Market
    • 8.8.2.South Africa Manufacturing Execution System in Life Sciences Market
    • 8.8.3.Rest of Middle East & Africa Manufacturing Execution System in Life Sciences Market

Chapter 9.Competitive Intelligence

  • 9.1.Key Company SWOT Analysis
  • 9.2.Top Market Strategies
  • 9.3.Company Profiles
    • 9.3.1. Korber AG
      • 9.3.1.1.Key Information
      • 9.3.1.2.Overview
      • 9.3.1.3.Financial (Subject to Data Availability)
      • 9.3.1.4.Product Summary
      • 9.3.1.5.Recent Developments
    • 9.3.2. ABB Laboratories
    • 9.3.3.MasterControl Solutions, Inc.
    • 9.3.4.AVEVA Group Limited
    • 9.3.5.Cognizant Technology Solutions Corporation
    • 9.3.6.Rockwell Automation
    • 9.3.7.Nagarro, Inc
    • 9.3.8.Siemens AG
    • 9.3.9.Emerson Electric Co.
    • 9.3.10.iBase-t, Inc.

Chapter 10.Research Process

  • 10.1.Research Process
    • 10.1.1.Data Mining
    • 10.1.2.Analysis
    • 10.1.3.Market Estimation
    • 10.1.4.Validation
    • 10.1.5.Publishing
  • 10.2.Research Attributes
  • 10.3.Research Assumption

LIST OF TABLES

  • TABLE 1.Global Manufacturing Execution System in Life Sciences Market, report scope
  • TABLE 2.Global Manufacturing Execution System in Life Sciences Market estimates & forecasts by Region 2020-2030 (USD Billion)
  • TABLE 3.Global Manufacturing Execution System in Life Sciences Market estimates & forecasts by Solution Type 2020-2030 (USD Billion)
  • TABLE 4.Global Manufacturing Execution System in Life Sciences Market estimates & forecasts by Deployment 2020-2030 (USD Billion)
  • TABLE 5.Global Manufacturing Execution System in Life Sciences Market estimates & forecasts by End-user 2020-2030 (USD Billion)
  • TABLE 6.Global Manufacturing Execution System in Life Sciences Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 7.Global Manufacturing Execution System in Life Sciences Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 8.Global Manufacturing Execution System in Life Sciences Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 9.Global Manufacturing Execution System in Life Sciences Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 10.Global Manufacturing Execution System in Life Sciences Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 11.Global Manufacturing Execution System in Life Sciences Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 12.Global Manufacturing Execution System in Life Sciences Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 13.Global Manufacturing Execution System in Life Sciences Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 14.Global Manufacturing Execution System in Life Sciences Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 15.Global Manufacturing Execution System in Life Sciences Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 16.U.S. Manufacturing Execution System in Life Sciences Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 17.U.S. Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 18.U.S. Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 19.Canada Manufacturing Execution System in Life Sciences Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 20.Canada Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 21.Canada Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 22.UK Manufacturing Execution System in Life Sciences Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 23.UK Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 24.UK Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 25.Germany Manufacturing Execution System in Life Sciences Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 26.Germany Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 27.Germany Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 28.France Manufacturing Execution System in Life Sciences Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 29.France Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 30.France Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 31.Italy Manufacturing Execution System in Life Sciences Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 32.Italy Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 33.Italy Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 34.Spain Manufacturing Execution System in Life Sciences Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 35.Spain Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 36.Spain Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 37.RoE Manufacturing Execution System in Life Sciences Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 38.RoE Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 39.RoE Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 40.China Manufacturing Execution System in Life Sciences Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 41.China Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 42.China Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 43.India Manufacturing Execution System in Life Sciences Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 44.India Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 45.India Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 46.Japan Manufacturing Execution System in Life Sciences Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 47.Japan Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 48.Japan Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 49.South Korea Manufacturing Execution System in Life Sciences Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 50.South Korea Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 51.South Korea Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 52.Australia Manufacturing Execution System in Life Sciences Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 53.Australia Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 54.Australia Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 55.RoAPAC Manufacturing Execution System in Life Sciences Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 56.RoAPAC Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 57.RoAPAC Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 58.Brazil Manufacturing Execution System in Life Sciences Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 59.Brazil Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 60.Brazil Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 61.Mexico Manufacturing Execution System in Life Sciences Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 62.Mexico Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 63.Mexico Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 64.RoLA Manufacturing Execution System in Life Sciences Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 65.RoLA Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 66.RoLA Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 67.Saudi Arabia Manufacturing Execution System in Life Sciences Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 68.South Africa Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 69.RoMEA Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 70.List of secondary sources, used in the study of Global Manufacturing Execution System in Life Sciences Market
  • TABLE 71.List of primary sources, used in the study of Global Manufacturing Execution System in Life Sciences Market
  • TABLE 72.Years considered for the study
  • TABLE 73.Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

  • FIG 1.Global Manufacturing Execution System in Life Sciences Market, research methodology
  • FIG 2.Global Manufacturing Execution System in Life Sciences Market, Market estimation techniques
  • FIG 3.Global Market size estimates & forecast methods
  • FIG 4.Global Manufacturing Execution System in Life Sciences Market, key trends 2022
  • FIG 5.Global Manufacturing Execution System in Life Sciences Market, growth prospects 2023-2030
  • FIG 6.Global Manufacturing Execution System in Life Sciences Market, porters 5 force model
  • FIG 7.Global Manufacturing Execution System in Life Sciences Market, pest analysis
  • FIG 8.Global Manufacturing Execution System in Life Sciences Market, value chain analysis
  • FIG 9.Global Manufacturing Execution System in Life Sciences Market by segment, 2020 & 2030 (USD Billion)
  • FIG 10.Global Manufacturing Execution System in Life Sciences Market by segment, 2020 & 2030 (USD Billion)
  • FIG 11.Global Manufacturing Execution System in Life Sciences Market by segment, 2020 & 2030 (USD Billion)
  • FIG 12.Global Manufacturing Execution System in Life Sciences Market by segment, 2020 & 2030 (USD Billion)
  • FIG 13.Global Manufacturing Execution System in Life Sciences Market by segment, 2020 & 2030 (USD Billion)
  • FIG 14.Global Manufacturing Execution System in Life Sciences Market, regional snapshot 2020 & 2030
  • FIG 15.North America Manufacturing Execution System in Life Sciences Market 2020 & 2030 (USD Billion)
  • FIG 16.Europe Manufacturing Execution System in Life Sciences Market 2020 & 2030 (USD Billion)
  • FIG 17.Asia Pacific Manufacturing Execution System in Life Sciences Market 2020 & 2030 (USD Billion)
  • FIG 18.Latin America Manufacturing Execution System in Life Sciences Market 2020 & 2030 (USD Billion)
  • FIG 19.Middle East & Africa Manufacturing Execution System in Life Sciences Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable